Brief: Vicore Reports Positive Results From Pulmonary Fibrosis Study

Vicore Pharma Holding AB

04/01/2024 07:05

Jan 4 (Reuters) - Vicore Pharma Holding AB  VICOR.ST :
    * REPORTS POSITIVE RESULTS FOR THE PIVOTAL STUDY OF ITS
DIGITAL
THERAPY FOR PATIENTS WITH PULMONARY FIBROSIS
    * COMPANION PIVOTAL STUDY MET PRIMARY ENDPOINT AND
DEMONSTRATED
SIGNIFICANTLY REDUCED ANXIETY IN PATIENTS WITH PULMONARY
FIBROSIS
    * STUDY MET ITS PRIMARY ENDPOINT WITH STATISTICALLY
SIGNIFICANT
2.7-POINT IMPROVEMENT OF ANXIETY SYMPTOMS IN GROUP TREATED WITH
ALMEE COMPARED TO CONTROL

Source text for Eikon:  ID:nMFN5bZKjd 
Further company coverage:  VICOR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))